Duo Wang
Impact in
-
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Pluripotent Stem Cells Research 2
- Glycosylation and Glycoproteins Research 1
-
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Junjie Liu (4 shared papers)Kun Zhang (3 shared papers)Danke Su (2 shared papers)Xin Huang (1 shared paper)Xiaofeng Ma (1 shared paper)Guanhua Qiu (3 shared papers)Haihong Ye (1 shared paper)Yuee Teng (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Advanced Science (1 paper)Medicine (1 paper)Brain Research (1 paper)Advanced Functional Materials (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Duo Wang
23 papers receiving 440 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 69
- Molecular Biology 206
- Biomedical Engineering 115
- Immunology 47
- Biomaterials 29
Countries citing papers authored by Duo Wang
This map shows the geographic impact of Duo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duo Wang more than expected).
Fields of papers citing papers by Duo Wang
This network shows the impact of papers produced by Duo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duo Wang. The network helps show where Duo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Duo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 100 | |
| 2 | 2021 | 91 | |
| 3 | 2022 | 37 | |
| 4 | 1999 | 31 | |
| 5 | 2020 | 28 | |
| 6 | 2016 | 22 | |
| 7 | Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. | 1995 | 21 |
| 8 | 2019 | 15 | |
| 9 | 2017 | 14 | |
| 10 | 2016 | 14 | |
| 11 | 2017 | 13 | |
| 12 | 2024 | 13 | |
| 13 | 2021 | 13 | |
| 14 | 2018 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2023 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2017 | 3 | |
| 19 | 2025 | 3 | |
| 20 | [The expression of c-fos and transmitter calcitonin gene-related peptide in the chronic compressive injury of the nerve root]. | 2004 | 2 |
About Duo Wang
Duo Wang is a scholar working on Molecular Biology, Biomedical Engineering, Parasitology, Materials Chemistry and Surgery, having authored 24 papers that have together received 444 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Advanced Nanomaterials in Catalysis (3 papers), Pluripotent Stem Cells Research (2 papers), Toxoplasma gondii Research Studies (2 papers), Glycosylation and Glycoproteins Research (1 paper), Ferroptosis and cancer prognosis (1 paper), Advanced Photocatalysis Techniques (1 paper) and Blockchain Technology Applications and Security (1 paper). The work is most often cited by research in Cancer Research (69 citations), Molecular Biology (206 citations), Biomedical Engineering (115 citations), Immunology (47 citations) and Biomaterials (29 citations). Duo Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Junjie Liu, Kun Zhang, Danke Su, Xin Huang, Xiaofeng Ma, Guanhua Qiu, Haihong Ye, Yuee Teng, Yunpeng Liu and Jing Feng. Their work appears in journals such as Frontiers in Oncology, Advanced Science, Medicine, Brain Research and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.